Results 281 to 290 of about 482,781 (345)
The impact of COVID‐19 on public perceptions of wild meat in Central Africa
Abstract Wild meat is a significant source of food and income generation in Central Africa. However, there is little knowledge of how the assumed link between COVID‐19 and wild meat consumption has been discussed by the media and received by the public. In this study, we conducted media content analysis of 264 articles published in 2019–2020 related to
Yuhan Li +14 more
wiley +1 more source
Infections nosocomiales à coronavirus humains chez le nouveau-né
Arnaud Gagneur +6 more
openalex +1 more source
Expression of SARS‐CoV‐2 entry‐associated proteins in COPD airways: an immunohistochemical study
Abstract Coronavirus disease 2019 (COVID‐19) is of special concern to patients with chronic obstructive pulmonary disease (COPD), given their susceptibility to exacerbations caused by respiratory tract infections. As the susceptibility of acquiring a SARS‐CoV‐2 infection in COPD remains unclear, this study explored the airway expression of SARS‐CoV‐2 ...
Larissa E Vlaming‐van Eijk +5 more
wiley +1 more source
The study explored the clinical characteristics and risk factors of HBoV‐positive severe pneumonia in children. These findings indicate that HBoV can be identified in respiratory samples from children with severe pneumonia, denoting its role as a viral pathogen in hospitalized children with this condition.
Jing Liao +6 more
wiley +1 more source
Increasing incidence of pediatric inflammatory bowel disease (IBD) and suboptimal vaccination coverage in Apulia, Italy (2009–2023). A total of 1044 incident cases of paediatric IBD were identified in the period 2009–2023 in Apulia, Italy, giving an average annual standardized incidence rate of 12.7/100 000. A significant increase in incidence occurred
Francesca Fortunato +4 more
wiley +1 more source
Severe Coronavirus Infections in Pregnancy: A Systematic Review. [PDF]
Galang RR +11 more
europepmc +1 more source
Developing New Drugs for the COVID‐19 Emergency: Anatomy of the U.S. Response
ABSTRACT Context To meet the need for effective treatments during the COVID‐19 Public Health Emergency, the U.S. government sought to accelerate the discovery and development of new antiviral treatments—a process that normally took 4–12 years.
Thomas J. Moore +2 more
wiley +1 more source

